Plain-English translation of NCT05562466 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Asthma research guide →Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing a new asthma medication called (indacaterol acetate/mometasone furoate) to see if it controls asthma better than , a commonly used asthma inhaler. The study will enroll about 200 children ages 6 to 11 who have asthma that isn't fully controlled by low-dose steroid inhalers alone. Each child will try both medications over the course of the study to help doctors understand which one works better.
Some children need more than just a low-dose steroid inhaler to control their asthma symptoms. This trial is testing whether the medication works better than the standard treatment, which could give families another option for managing their child's asthma.
You likely qualify if…
You likely don't qualify if…
You will visit the clinic about 10 times over 37 weeks. First, there's a 3-week screening and preparation period where you'll take a standard inhaler and complete breathing tests. Then you'll take the new medication for 12 weeks, stop it for 3 weeks (returning to the standard inhaler), and then switch to take the comparison medication for another 12 weeks. Throughout the study, you'll keep a diary of your asthma symptoms and have regular check-ins with the research team to make sure the medication is working safely.
AI-generated summary from trial data · Sep 4, 2026 · Not medical advice
Argentina